Author: Peter Mansell

A consortium of European universities, research institutes and companies including GlaxoSmithKline and UK-based biotech Redx Pharma has launched an €85 million programme under the Innovative Medicines Initiative (IMI) to develop novel antibiotics against Gram-negative pathogens.

US-based biopharmaceutical services provider PAREXEL International has rebranded its technology subsidiary, Perceptive Informatics, to PAREXEL Informatics as part of an ongoing effort to create a more integrated package of services.

Theorem Clinical Research, the US-based provider of clinical research and development services, has formed a strategic alliance with Decision Driver Analytics to bring more health economics and outcomes research (HEOR) insights into product development.

Industry, researchers and animal rights groups have reacted with a mixture of applause, qualified approval and fury to the UK government’s newly published delivery plan for its 3Rs policy on the use of animals in bioscience research.

Berry Consultants, the US-based consulting group specialising in the Bayesian approach to medical statistics, has acquired full ownership of the FACTS (Fixed and Adaptive Clinical Trial Simulator) tool from Tessella, joint developer of the software.